Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need
BioSpace
Mon, 03/18/24 - 05:19 pm
AstraZeneca
Lynparza
Imfinzi
endometrial cancer
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
M&A
Bristol Myers Squibb
Novartis
AstraZeneca
Novo Nordisk
Pfizer
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
Reuters
Mon, 03/18/24 - 11:05 am
AstraZeneca
inhalers
drug pricing
Boehringer Ingelheim
Airsupra
Bevespi Aerosphere
Breztri Aerosphere
COPD
AstraZeneca boosts rare disease portfolio with $1.05B Amolyt acquisition
BioSpace
Thu, 03/14/24 - 11:38 am
AstraZeneca
M&A
Amolyt Pharma
eneboparatide
hypoparathyroidism
AstraZeneca kick-starts Phase III COPD trial for Breztri
Clinical Trials Arena
Thu, 03/14/24 - 11:21 am
AstraZeneca
COPD
clinical trials
Breztri
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Sanofi
AstraZeneca
Beyfortus
RSV
monoclonal antibodies
AstraZeneca to invest 650 million pounds in UK to boost 'pandemic preparedness'
Reuters
Wed, 03/6/24 - 11:18 am
AstraZeneca
pandemic
UK
Surprise Enhertu rejection follows NICE process change
Pharmaphorum
Tue, 03/5/24 - 11:35 am
AstraZeneca
Daiichi Sankyo
HER2-low breast cancer
Enhertu
NICE
UK
AstraZeneca’s drug pricing lawsuit dismissed by federal judge
BioPharma Dive
Mon, 03/4/24 - 11:46 pm
AstraZeneca
drug pricing
legal
Medicare
Inflation Reduction Act
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
oncology
cancer
antibody-drug conjugate
Merck
AbbVie
Pfizer
AstraZeneca
AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure
Fierce Pharma
Tue, 02/27/24 - 11:16 am
AstraZeneca
FibroGen
roxadustat
anemia
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
What did Big Pharma CEOs get paid in 2023?
Medical Marketing and Media
Fri, 02/23/24 - 10:22 am
Pharma CEOs
executive pay
AstraZeneca
Roche
Novartis
Daiichi Sankyo and AstraZeneca’s lung cancer antibody set for FDA review
Clinical Trials Arena
Tue, 02/20/24 - 11:30 am
Daiichi Sankyo
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
AstraZeneca’s Evusheld fails to improve Covid outcomes in Phase III trial
Clinical Trials Arena
Tue, 02/20/24 - 11:01 am
AstraZeneca
Evusheld
clinical trials
COVID-19
FDA approves AstraZeneca's Tagrisso-chemo combo
Reuters
Sun, 02/18/24 - 08:26 pm
AstraZeneca
Tagrisso
lung cancer
FDA
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
AstraZeneca’s year-end revenues rise but Wall Street remains unimpressed
Medical Marketing and Media
Thu, 02/8/24 - 11:23 am
AstraZeneca
earnings
COVID-19
AstraZeneca to invest $300 million in US facility for cell therapies
Reuters
Tue, 02/6/24 - 11:38 pm
AstraZeneca
cell therapy
AstraZeneca's phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Fierce Biotech
Fri, 02/2/24 - 11:53 am
AstraZeneca
Pfizer
acoramidis
Japan
clinical trials
cardiomyopathy
ATTR-CM
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »